Article
Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients.
British journal of cancer - 1 Mar 2022
Larsen S G, Goscinski M A, Dueland S, Steigen S E, Hofsli E, Torgunrud A, Lund-Iversen M, Dagenborg V J, Flatmark K, Sorbye H
Abstract excerpt
BACKGROUND: Patients with metastatic colorectal cancer (mCRC) carrying BRAF (mutBRAF) or KRAS mutation (mutKRAS) have an inferior prognosis after liver or lung surgery, whereas the prognostic role in the context of peritoneal metastasis (PM) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has been less investigated. METHODS: In total, 257 patients with non-appendiceal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
